618 related articles for article (PubMed ID: 25643272)
21. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
[TBL] [Abstract][Full Text] [Related]
22. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
23. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
[TBL] [Abstract][Full Text] [Related]
24. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States.
Pesesky MW; Hussain T; Wallace M; Wang B; Andleeb S; Burnham CA; Dantas G
Emerg Infect Dis; 2015 Jun; 21(6):1034-7. PubMed ID: 25988236
[TBL] [Abstract][Full Text] [Related]
25. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Cantón R; Canut A; Morosini MI; Oliver A
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
27. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
[TBL] [Abstract][Full Text] [Related]
28. KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.
Baraniak A; Izdebski R; Fiett J; Herda M; Derde LP; Bonten MJ; Adler A; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M;
Antimicrob Agents Chemother; 2015 Dec; 60(3):1912-7. PubMed ID: 26711772
[TBL] [Abstract][Full Text] [Related]
29. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
Falagas ME; Karageorgopoulos DE; Nordmann P
Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
[TBL] [Abstract][Full Text] [Related]
31. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
32. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
[TBL] [Abstract][Full Text] [Related]
33. [Carbapenemases in enterobacteriaceae].
Nordmann P; Carrer A
Arch Pediatr; 2010 Sep; 17 Suppl 4():S154-62. PubMed ID: 20826325
[TBL] [Abstract][Full Text] [Related]
34. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Gupta N; Limbago BM; Patel JB; Kallen AJ
Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
[TBL] [Abstract][Full Text] [Related]
36. Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel.
Lerner A; Solter E; Rachi E; Adler A; Rechnitzer H; Miron D; Krupnick L; Sela S; Aga E; Ziv Y; Peretz A; Labay K; Rahav G; Geffen Y; Hussein K; Eluk O; Carmeli Y; Schwaber MJ
Eur J Clin Microbiol Infect Dis; 2016 Jan; 35(1):149-54. PubMed ID: 26581423
[TBL] [Abstract][Full Text] [Related]
37. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
[TBL] [Abstract][Full Text] [Related]
38. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
39. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
40. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
